查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1523300

藥物釋放型支架市場報告：2030 年趨勢、預測與競爭分析

Drug-Eluting Stent Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

藥物釋放型支架的趨勢與預測

預計到 2030 年，全球藥物釋放型支架市場將達到 128 億美元，2024 年至 2030 年複合年成長率為 6.3%。該市場的主要促進因素是全球老年人口的增加和心血管疾病發生率的上升。全球藥物釋放型支架市場的未來充滿希望，冠狀動脈疾病和周邊動脈疾病市場存在著機會。

藥物釋放型支架按細分市場

該研究包括按塗層類型、應用和地區對全球藥物釋放型支架市場的預測。

藥物釋放型支架市場洞察

Lucintel 預測，由於其經過驗證的有效性和適應性，聚合物基塗料在預測期內將繼續成為更大的細分市場。

在這個市場中，由於冠狀動脈疾病的全球盛行率不斷增加，冠狀動脈疾病將繼續佔據很大一部分。

由於其發達的醫療基礎設施和先進醫療技術的廣泛採用，北美在預測期內將繼續成為最大的地區。

常問問題

Q1.市場規模為：

A1. 到2030年，全球藥物釋放型支架市場預計將達到128億美元。

Q2.市場成長預測是多少：

A2. 2024年至2030年，全球藥物釋放型支架市場預計將以6.3%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要促進因素是全球老年人口的增加和心血管疾病發生率的上升。

Q4.市場的主要細分市場是：

A4.藥物釋放型支架市場前景廣闊，冠狀動脈疾病和周邊動脈疾病市場充滿機會。

Q5.市場的主要企業是：

A5.主要的藥物釋放型支架公司如下：

  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Biosensors
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical
  • Cook Medical
  • Shandong JW Medical Systems
  • B.Braun

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，在預測期內，基於聚合物的塗料將繼續成為一個更大的細分市場，因為它已經證明了其有效性和適應性。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 由於其發達的醫療基礎設施和先進醫療技術的廣泛採用，北美在預測期內仍然是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球藥物釋放型支架市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球藥物釋放型支架市場趨勢（2018-2023）與預測（2024-2030）
  • 按塗層類型分類的全球藥物釋放型支架市場
    • 聚合物基塗料
    • 無聚合物塗層
  • 按應用分列的全球藥物釋放型支架市場
    • 冠狀動脈疾病
    • 周邊動脈疾病

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球藥物釋放型支架市場區域分佈
  • 北美藥物釋放型支架市場
  • 歐洲藥物釋放型支架市場
  • 亞太地區藥物釋放型支架市場
  • 其他地區藥物釋放型支架市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
  • 全球藥物釋放型支架市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球藥物釋放型支架市場產能
    • 全球藥物釋放型支架市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Biosensors
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical
  • Cook Medical
  • Shandong JW Medical Systems
  • B.Braun
簡介目錄

Drug-Eluting Stent Trends and Forecast

The future of the global drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets. The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 6.3% from 2024 to 2030. The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Drug-Eluting Stent by Segment

The study includes a forecast for the global drug-eluting stent by coating type, application, and region.

Drug-Eluting Stent Market by Coating Type [Shipment Analysis by Value from 2018 to 2030]:

  • Polymer-Based Coating
  • Polymer-Free Coating

Drug-Eluting Stent Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Drug-Eluting Stent Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Drug-Eluting Stent Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies drug-eluting stent companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the drug-eluting stent companies profiled in this report include-

  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Biosensors
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical
  • Cook Medical
  • Shandong JW Medical Systems
  • B.Braun

Drug-Eluting Stent Market Insights

Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.

Within this market, coronary artery disease will remain larger segment due to increasing global incidence of coronary artery disease.

North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.

Features of the Global Drug-Eluting Stent Market

Market Size Estimates: Drug-eluting stent market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Drug-eluting stent market size by coating type, application, and region in terms of value ($B).

Regional Analysis: Drug-eluting stent market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different coating types, applications, and regions for the drug-eluting stent market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the drug-eluting stent market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the drug-eluting stent market size?

Answer: The global drug-eluting stent market is expected to reach an estimated $12.8 billion by 2030.

Q2. What is the growth forecast for drug-eluting stent market?

Answer: The global drug-eluting stent market is expected to grow with a CAGR of 6.3% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the drug-eluting stent market?

Answer: The major drivers for this market are increasing global elderly population and rising incidence of cardiovascular disorders.

Q4. What are the major segments for drug-eluting stent market?

Answer: The future of the drug-eluting stent market looks promising with opportunities in the coronary artery disease and peripheral artery disease markets.

Q5. Who are the key drug-eluting stent market companies?

Answer: Some of the key drug-eluting stent companies are as follows:

  • Boston Scientific
  • Medtronic
  • Abbott Laboratories
  • Biosensors
  • Biotronik
  • Lepu Medical Technology
  • Terumo Medical
  • Cook Medical
  • Shandong JW Medical Systems
  • B.Braun

Q6. Which drug-eluting stent market segment will be the largest in future?

Answer: Lucintel forecasts that polymer-based coatings will remain larger segment over the forecast period due to its proven effectiveness and adaptability.

Q7. In drug-eluting stent market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to presence of well-developed healthcare infrastructure and widespread adoption of advanced medical technologies in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the drug-eluting stent market by coating type (polymer-based coating and polymer-free coating), application (coronary artery disease and peripheral artery disease), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Drug-Eluting Stent Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Drug-Eluting Stent Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Drug-Eluting Stent Market by Coating Type
    • 3.3.1: Polymer-Based Coating
    • 3.3.2: Polymer-Free Coating
  • 3.4: Global Drug-Eluting Stent Market by Application
    • 3.4.1: Coronary Artery Disease
    • 3.4.2: Peripheral Artery Disease

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Drug-Eluting Stent Market by Region
  • 4.2: North American Drug-Eluting Stent Market
    • 4.2.1: North American Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
    • 4.2.2: North American Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
  • 4.3: European Drug-Eluting Stent Market
    • 4.3.1: European Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
    • 4.3.2: European Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
  • 4.4: APAC Drug-Eluting Stent Market
    • 4.4.1: APAC Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
    • 4.4.2: APAC Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease
  • 4.5: ROW Drug-Eluting Stent Market
    • 4.5.1: ROW Drug-Eluting Stent Market by Coating Type: Polymer-Based Coating and Polymer-Free Coating
    • 4.5.2: ROW Drug-Eluting Stent Market by Application: Coronary Artery Disease and Peripheral Artery Disease

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Drug-Eluting Stent Market by Coating Type
    • 6.1.2: Growth Opportunities for the Global Drug-Eluting Stent Market by Application
    • 6.1.3: Growth Opportunities for the Global Drug-Eluting Stent Market by Region
  • 6.2: Emerging Trends in the Global Drug-Eluting Stent Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Drug-Eluting Stent Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Drug-Eluting Stent Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Boston Scientific
  • 7.2: Medtronic
  • 7.3: Abbott Laboratories
  • 7.4: Biosensors
  • 7.5: Biotronik
  • 7.6: Lepu Medical Technology
  • 7.7: Terumo Medical
  • 7.8: Cook Medical
  • 7.9: Shandong JW Medical Systems
  • 7.10: B.Braun